Skip to content

The prenatal course of CF

The prenatal course of cystic fibrosis: prediction of meconium ileus, possibilities for treatment. - The prenatal course of CF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58196
Enrollment
50
Registered
2025-10-08
Start date
2026-01-03
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic fibrosis Cystic fibrosis

Interventions

Not applicable.

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women that underwent sonographic evaluation during pregnancy (GUO), for any indicationOffspring with confirmed cystic fibrosis diagnosis either pre- or postnatal

Exclusion criteria

Exclusion criteria: Patients that have objected against use of their data for research purposes. 

Design outcomes

Primary

MeasureTime frame
- Maternal characteristics such as gravida, parity, gestational age at diagnosis and at follow up ultrasound, underlying maternal disease, obstetric complications (such as preeclampsia), mode of birth, continuation or termination of pregnancy.- Fetal characteristics including genetic diagnosis, fetal bowel ultrasound findings and longitudinal follow up, associated structural abnormalities, amniotic fluid volume, fetal Doppler (umbilical artery and middle cerebral artery).- Neonatal outcomes including: gestational age at birth, birthweight, gender, presence of meconium plug, postnatal bowel imaging, postnatal bowel surgery findings, hospital days, necessity of respiratory support, presence of complications at surgery, additional structural abnormalities, management strategy for cystic fibrosis, other?

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Contacts

Public ContactA.B. Zijlmans

Erasmus MC, Universitair Medisch Centrum Rotterdam

a.zijlmans@erasmusmc.nl010-7040704

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)